Cite
HARVARD Citation
Yagi, K. et al. (2021). Diastolic Cardiac Function Improvement by Liraglutide Is Mainly Body Weight Reduction Dependent but Independently Contributes to B-Type Natriuretic Peptide Reduction in Patients with Type 2 Diabetes with Preserved Ejection Fraction. Journal of diabetes research. p. . [Online].